Banu Arun
The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology
Most-Cited Works
- → Association analysis identifies 65 new breast cancer risk loci(2017)1,557 cited
- → Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer(2005)1,165 cited
- → PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression(2017)954 cited
- → American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility(2015)940 cited
- → Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer(2011)600 cited
- → Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer(2008)600 cited
- → Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer(2002)570 cited
- → Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer(2004)568 cited
- → Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses(2020)551 cited
- → Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer(2017)542 cited